Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Bundred, Nigel; Porta, Nuria; Brunt, Adrian Murray; Cramer, Angela; Hanby, Andrew; M. Shaaban, Abeer; Rakha, Emad A.; Armstrong, Anne; Cutress, Ramsey I.; Dodwell, David; Emson, Marie A.; Evans, Abigail; M. Hartup, Sue; Horgan, Kieran; Miller, Sarah E.; McIntosh, Stuart A.; Morden, James P.; Naik, Jay; Narayanan, Sankaran; Ooi, Jane; Skene, Anthony I.; Cameron, David A.; Bliss, Judith M.

doi:10.1158/1078-0432.c.6532623

All Outputs (4)

Investigating physical comorbidity in people with severe mental illness in South Asia (2023)
Dataset
Zavala Gomez, G., Rajan, S., Mitchell, A., Zavala, G. A., Podmore, D., Khali, H., …Siddiqi, K. (2023). Investigating physical comorbidity in people with severe mental illness in South Asia. [Dataset]. https://doi.org/10.1186/isrctn88485933

Addressing Child and Adolescent Musculoskeletal Pain: the CAM-Pain Programme - Code Lists (2023)
Dataset
Jordan, K., Mason, K., Bailey, J., Protheroe, J., Mughal, F., Thomas, M., …Dunn, K. (2023). Addressing Child and Adolescent Musculoskeletal Pain: the CAM-Pain Programme - Code Lists. [Dataset]

SNOMED Clinical terminology and Clinical Practice Record Datalink (CPRD) AURUM dataset code lists from CAM-Pain programme 2023: The aim of the CAM-Pain programme is to improve the understanding, self-management, impact and healthcare of musculoske... Read More about Addressing Child and Adolescent Musculoskeletal Pain: the CAM-Pain Programme - Code Lists.

Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results (2023)
Dataset
Bundred, N., Porta, N., Brunt, A. M., Cramer, A., Hanby, A., Shaaban, A. M., …Bliss, J. M. (2023). Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. [Dataset]. https://doi.org/10.1158/1078-0432.c.6532623.v1

Purpose: EPHOS-B aimed to determine whether perioperative anti-HER2 therapy inhibited proliferation and/or increased apoptosis in HER2-positive breast cancer. Patients and Methods: This randomized phase II, two-part, multicenter trial included n... Read More about Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.

Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results (2023)
Dataset
Bundred, N., Porta, N., Brunt, A. M., Cramer, A., Hanby, A., M. Shaaban, A., …Bliss, J. M. (2023). Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. [Dataset]. https://doi.org/10.1158/1078-0432.c.6532623

Purpose: EPHOS-B aimed to determine whether perioperative anti-HER2 therapy inhibited proliferation and/or increased apoptosis in HER2-positive breast cancer. Patients and Methods: This randomized phase II, two-part, multicenter trial included n... Read More about Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.